Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Cyclofenil

From Wikipedia, the free encyclopedia
Chemical compound
Not to be confused withCycloguanil.
Pharmaceutical compound
Cyclofenil
Clinical data
Trade namesSexovid, others
Other namesCyclophenil; F-6066; H-3452; ICI-48213; bis(p-Acetoxyphenyl)-cyclohexylidenemethane
AHFS/Drugs.comInternational Drug Names
Routes of
administration
By mouth
Drug classSelective estrogen receptor modulator;Progonadotropin
ATC code
Pharmacokinetic data
Eliminationhalf-life18–29 hours[1][2]
Identifiers
  • [4-[(4-Acetoxyphenyl)-cyclohexylidene-methyl]phenyl] acetate
CAS Number
PubChemCID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.018.264Edit this at Wikidata
Chemical and physical data
FormulaC23H24O4
Molar mass364.441 g·mol−1
3D model (JSmol)
  • O=C(Oc3ccc(C(/c1ccc(OC(=O)C)cc1)=C2\CCCCC2)cc3)C

Cyclofenil, sold under the brand nameSexovid among others, is aselective estrogen receptor modulator (SERM) medication which is used as agonadotropin stimulant orovulation inducer and inmenopausal hormone therapy in women.[3][4][5][6] It is mostly no longer available.[6] The medication is takenby mouth.[7][8][9]

Side effects of cyclofenil includeliver toxicity among others.[10] It is aselective estrogen receptor modulator (SERM) and hence is a mixedagonistantagonist of theestrogen receptor (ER), thebiological target ofestrogens likeestradiol.[8] It hasantiestrogenic effects on thehypothalamic–pituitary–gonadal axis and hence can increasesex hormone production and stimulateovulation.[8][11]

Cyclofenil was introduced for medical use in 1970.[12] It has been mostly discontinued, but remains available in a few countries, includingBrazil,Italy, andJapan.[6][13][3] It has been used as adoping agent by maleathletes.[8]

Medical use

[edit]

Cyclofenil is used to treatmenstrual disturbances andanovulatoryinfertility caused by insufficiency of thehypothalamic–pituitary–gonadal axis in women.[3] It has also been used to treatmenopausal symptoms.[3] The medication is generally used at a dosage of 400 to 600 mg per day.[3][8][9]

Available forms

[edit]

Cyclofenil has been available in the form of 100, 200, and 400 mgoraltablets.[8]

Non-medical use

[edit]

Cyclofenil has been used by maleathletes to increasetestosterone levels.[8] It is not effective for this purpose in women.[8]

Contraindications

[edit]

Cyclofenil iscontraindicated duringpregnancy and in those with severeliver disease and unexplaineduterine bleeding.[14]

Side effects

[edit]

Cyclofenil is associated with a relatively high incidence ofhepatotoxicity.[10] Biochemical signs of undesirable liver changes have been observed in 35% or more of individuals and 1% of individuals experience overthepatitis.[10]

Pharmacology

[edit]

Pharmacodynamics

[edit]

Cyclofenil is a SERM, or a mixedagonist andantagonist of theestrogen receptors (ERs).[8] It is described as a relatively weak/mild SERM.[8] The medication is generally less effective than other SERMs.[15] The medication is an "impeded estrogen" and is thought to work as aprogonadotropin by blocking the actions of estrogens in thepituitary gland andhypothalamus, thereby disinhibiting release of thegonadotropinsluteinizing hormone andfollicle-stimulating hormone.[11] In men, cyclofenil can increasetestosterone levels due its progonadotropic effects.[8]

Pharmacokinetics

[edit]

In terms ofdistribution, cyclofenil acts bothcentrally and peripherally.[15] Theelimination half-life of cyclofenil after a single 200 mg dose is 18 to 29 hours.[1][2]

Chemistry

[edit]

Cyclofenil is anonsteroidal SERM and is closely related structurally totriphenylethylene SERMs likeclomifene andtamoxifen.[9] It has been referred to as a diphenylethylenederivative, differing from triphenylethylenes only by the replacement of one of thephenyl rings with acyclohexane ring.[16][11]

History

[edit]

Cyclofenil was first introduced for medical use in 1970 under the brand name Ondogyne inFrance.[12] Subsequently, it was introduced throughout the world under a variety of other brand names, including its most well-known brand name Sexovid.[12]

Society and culture

[edit]

Generic names

[edit]

Cyclofenil is theEnglishgeneric name of the drug and itsINNTooltip International Nonproprietary Name,USANTooltip United States Adopted Name, andBANTooltip British Approved Name.[4][5][6]

Brand names

[edit]

Cyclofenil has been marketed under a variety of brand names including Ciclifen, Fertodur, Gyneuro, Klofenil, Menoferil, Menopax, Neoclym, Oginex, Ondonid, Ondogyne, Rehibin, Sexadieno, Sexovar, and Sexovid.[17][12][13]

Availability

[edit]

Cyclofenil remains available today only inBrazil,Italy, andJapan.[6][13][3] In the past, it has also been available inFrance,Germany,Mexico,Sweden,Switzerland,Turkey, and theUnited Kingdom.[5][12][13][3]

Regulation

[edit]

Cyclofenil is included on theWorld Anti-Doping Agency list of illegal doping agents in sport.[18][19]

Research

[edit]

Cyclofenil was investigated as a possible treatment forscleroderma in the 1980s, but was found to be ineffective.[20] Later study of its efficacy in treatingRaynaud's phenomenon in people with scleroderma also found no significant benefit.[21]

References

[edit]
  1. ^abInsler V, Lunenfeld B (January 1993).Infertility: Male and Female. Churchill Livingstone. p. 458.ISBN 978-0-443-04514-1.
  2. ^abBlankstein J, Mashiach S, Lunenfeld B (1 July 1986).Ovulation Induction and in Vitro Fertilization. Year Book Medical Publishers. p. 113.ISBN 978-0-8151-0871-9.
  3. ^abcdefgSweetman SC, ed. (2009). "Sex hormones and their modulators".Martindale: The Complete Drug Reference (36th ed.). London: Pharmaceutical Press. p. 2088.ISBN 978-0-85369-840-1.
  4. ^abElks J (14 November 2014).The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 329–.ISBN 978-1-4757-2085-3.
  5. ^abcIndex Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 284–.ISBN 978-3-88763-075-1.
  6. ^abcde"List of 7 Menopausal Disorders Medications Compared".Drugs.com.
  7. ^Seyffart G (6 December 2012)."Cyclofenil".Drug Dosage in Renal Insufficiency. Springer Science & Business Media. pp. 166–.ISBN 978-94-011-3804-8.
  8. ^abcdefghijkvon Deutsch DA, Abukhalaf IK, Socci RR (15 October 2003)."Anabolic Doping Agents". In Mozayani A, Raymon L (eds.).Handbook of Drug Interactions: A Clinical and Forensic Guide. Springer Science & Business Media. pp. 555–.ISBN 978-1-59259-654-6.
  9. ^abcMeniru GI, Craft IL (31 July 1997)."Ovarian stimulation for assisted reproduction technologies". In Meniru GI, Brinsden PR, Craft IL (eds.).A Handbook of Intrauterine Insemination. Cambridge University Press. pp. 58–59, 207.ISBN 978-0-521-58676-4.
  10. ^abcZimmerman HJ, Ishak KG (6 December 2012)."Steroids and Other Hormones". In Cameron R, Feuer G, de la Iglesia F (eds.).Drug-Induced Hepatotoxicity. Springer Science & Business Media. pp. 565–.ISBN 978-3-642-61013-4.
  11. ^abcBishop PM (22 October 2013)."Clinical Manifestations of Disorders of the Human Ovary". In Zuckerman S, Weir BJ (eds.).Physiology. Elsevier Science. pp. 209–.ISBN 978-1-4832-5975-8.
  12. ^abcdeWilliam Andrew Publishing (22 October 2013).Pharmaceutical Manufacturing Encyclopedia (3rd ed.). Elsevier. pp. 1162–.ISBN 978-0-8155-1856-3.
  13. ^abcd"IBM Watson Health Products".IBM Watson Health Products. Retrieved2021-11-01.
  14. ^Mutschler E, Derendorf H, Schäfer-Korting M, Elrod K, Estes KS (1995)."Ovaries".Drug Actions: Basic Principles and Therapeutic Aspects. CRC Press. pp. 294–.ISBN 978-0-8493-7774-7.
  15. ^abTatford EP (6 December 2012)."Excessive Vaginal Bleeding".Problems in Gynaecology. Springer Science & Business Media. pp. 105–106.ISBN 978-94-009-4125-0.
  16. ^Horsky J (6 December 2012)."Oestrogens". In Horsky J, Presl J (eds.).Ovarian Function and its Disorders: Diagnosis and Therapy. Springer Science & Business Media. pp. 92–.ISBN 978-94-009-8195-9.
  17. ^Negwer M, Scharnow HG (2001).Organic-chemical drugs and their synonyms: (an international survey). Wiley-VCH. p. 2397.ISBN 978-3-527-30247-5.
  18. ^Chester N (13 November 2014)."Hormone and metabolic modulators". In Mottram DR, Chester N (eds.).Drugs in Sport. Routledge. pp. 117–.ISBN 978-1-134-70800-0.
  19. ^Ed The Emtree Editorial Team (1 January 2004).Doping Search Guide 2004: Over 10,000 Substance Names in Reference to the 2004 WADA (World Anti-Doping Agency) List of Prohibited Substances and Methods. Elsevier. p. 82.ISBN 978-0-444-51752-4.
  20. ^Torres MA, Furst DE (February 1990). "Treatment of generalized systemic sclerosis".Rheum Dis Clin North Am.16 (1):217–41.doi:10.1016/S0889-857X(21)01050-4.PMID 2406809.
  21. ^Pope J, Fenlon D, Thompson A, et al. (2000). Pope J (ed.)."Cyclofenil for Raynaud's phenomenon in progressive systemic sclerosis".Cochrane Database Syst Rev.1998 (2) CD000955.doi:10.1002/14651858.CD000955.PMC 7032887.PMID 10796397.
Estrogens
ERTooltip Estrogen receptor agonists
Progonadotropins
Antiestrogens
ERTooltip Estrogen receptor antagonists
(incl.SERMsTooltip selective estrogen receptor modulators/SERDsTooltip selective estrogen receptor downregulators)
Aromatase inhibitors
Antigonadotropins
Others
ERTooltip Estrogen receptor
Agonists
Mixed
(SERMsTooltip Selective estrogen receptor modulators)
Antagonists
GPERTooltip G protein-coupled estrogen receptor
Agonists
Antagonists
Unknown
Retrieved from "https://en.wikipedia.org/w/index.php?title=Cyclofenil&oldid=1314441606"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp